Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review
source: International Ophthalmology
year: 2023
authors: Xueting Li, Senmao Li, Wanlin Fan, Alexander C Rokohl, Sitong Ju, Xiaojun Ju, Yongwei Guo, Ludwig M Heindl
summary/abstract:Graves ophthalmopathy (GO), which occurs in autoimmune thyroid disease, can reduce patients’ quality of life due to its impact on visual function, physical appearance, and emotional health. Corticosteroids have been the first-line treatment for GO. More recently, the pathogenesis of GO has made significant progress. Various targeting biological agents and immunosuppressive agents make GO management more promising. Fully understanding GO pathogenesis and precise clinical management are beneficial for the prognosis of patients. Therefore, we conducted a comprehensive review of the medical management of GO and summarized research developments to highlight future research issues.
organization: University of Cologne, Germany; Aachen-Bonn-Cologne-Duesseldorf, Germany; Zhejiang University School of Medicine, ChinaDOI: 10.1007/s10792-022-02537-6
read more full text
myBinderRelated Content
-
What is Graves’ Disease? What is Hyperthyroidism? With Doctor David Schneider from University of WisconsinThis episode (interview with Dr. David S...
-
Teprotumumab Significantly Improves Proptosis in Thyroid eye DiseasePatients with thyroid eye disease treate...
-
The Medical University of South Carolina Health Graves’ Eye Disease ClinicThe Medical University of South Carolina...
-
Sandy Zhang-Nunes, MDSandy Zhang-Nunes, MD, earned her underg...
-
Which Factors Predict the Outcome of Radioactive Iodine Therapy of Graves’ Disease?Graves’ disease is the most common cau...
-
Mortality in Graves’ Orbitopathy is Increased and Influenced By Gender, Age and Pre-Existing Morbidity: A Nati...Introduction: It is unclear whether the...
-
Impaired Immune Regulation After Radioiodine Therapy for Graves’ Disease and the Protective Effect of Methimaz...Both therapies for Graves' disease (GD),...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google